(Q36017333)

11 August 2017

1 reference

title

The neuro-ophthalmology of multiple sclerosis. (English)

1 reference

11 August 2017

0 references

5

Steven Galetta

1 reference

11 August 2017

Elliot M Frohman

1

1 reference

11 August 2017

Teresa C Frohman

series ordinal

2

1 reference

11 August 2017

David S Zee

series ordinal

3

1 reference

11 August 2017

Roderick McColl

series ordinal

4

1 reference

11 August 2017

language of work or name

1 reference

1 February 2005

1 reference

11 August 2017

1 reference

11 August 2017

volume

4

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

111-121

1 reference

Practice parameter: the role of corticosteroids in the management of acute monosymptomatic optic neuritis. Report of the Quality Standards Subcommittee of the American Academy of Neurology

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

West Nile virus-associated optic neuritis and chorioretinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Ehrlichiosis optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

The multifocal visual evoked potential

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Brain magnetic resonance imaging in acute optic neuritis. Experience of the Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Clinical and magnetic resonance imaging in optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Spinal cord MRI in clinically isolated optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Optic neuritis treatment trial. One-year follow-up results

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Symptomatic retrochiasmal lesions in multiple sclerosis: clinical features, visual evoked potentials, and magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

The relation of retinal periphlebitis to multiple sclerosis and other neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Retinal periphlebitis and retinitis in multiple sclerosis. I. Pathologic characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Chronic periphlebitis retinae in multiple sclerosis. A histopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Retinal periphlebitis in multiple sclerosis: a marker of disease activity?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Inflammatory vasculitis in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Neurological disease activity in multiple sclerosis patients with periphlebitis retinae

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

1 reference

7 January 2021

Characteristics of chronic MS lesions in the cerebrum, brainstem, spinal cord, and optic nerve on T1-weighted MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

A hypothetical scheme for the brainstem control of vertical gaze

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

The pretectal syndrome: 206 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

The oculomotor integrator: testing of a neural network model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Investigations of the pathogenesis of acquired pendular nystagmus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Clinical and MRI correlates in 27 patients with acquired pendular nystagmus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Acquired pendular nystagmus in multiple sclerosis: clinical observations and the role of optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

1 reference

7 January 2021

Microsaccadic flutter

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

A paroxysmal ocular motility disorder in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Paroxysmal symptoms as the first manifestations of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Ocular contrapulsion in multiple sclerosis: clinical features and pathophysiological mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z score

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

A new measure of dysconjugacy in INO: the first-pass amplitude

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Saccade metrics in multiple sclerosis: versional velocity disconjugacy as the best clue?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Binocular saccadic eye movements in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Internuclear ophthalmoplegia. I. Saccades and dissociated nystagmus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Abduction nystagmus in internuclear ophthalmoplegia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Abnormalities of horizontal gaze. Clinical, oculographic and magnetic resonance imaging findings. II. Gaze palsy and internuclear ophthalmoplegia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Vertical vestibulo-ocular reflex, smooth pursuit and eye-head tracking dysfunction in internuclear ophthalmoplegia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

The one-and-a-half syndrome--a unilateral disorder of the pontine tegmentum: a study of 20 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Horizontal monocular saccadic failure: an unusual clinically isolated syndrome progressing to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Vertigo in MS: utility of positional and particle repositioning maneuvers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Benign paroxysmal positioning vertigo in multiple sclerosis: diagnosis, pathophysiology and therapeutic techniques

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

An unusual variant of the dorsal midbrain syndrome in MS: clinical characteristics and pathophysiologic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Paralysis of cranial nerves III, IV, and VI. Cause and prognosis in 1,000 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Bilateral sixth nerve palsy. Analysis of 125 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Isolated sixth-nerve palsies in younger adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Bilateral pontine gaze palsy. Nuclear magnetic resonance findings in presumed multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Divisional oculomotor nerve paresis caused by intrinsic brainstem disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Combined Trochlear Nerve Palsy and Internuclear Ophthalmoplegia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

Gaze-evoked blepharoclonus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2900992-0

7 January 2021

10.1016/S1474-4422(05)00992-0

Identifiers

DOI

1 reference

11 August 2017

1 reference